149 related articles for article (PubMed ID: 20640484)
1. The changed ultrastructure of fibrin networks during use of oral contraception and hormone replacement.
Pretorius E; Oberholzer HM; van der Spuy WJ; Meiring JH
J Thromb Thrombolysis; 2010 Nov; 30(4):502-6. PubMed ID: 20640484
[TBL] [Abstract][Full Text] [Related]
2. The use of a desktop scanning electron microscope as a diagnostic tool in studying fibrin networks of thrombo-embolic ischemic stroke.
Pretorius E
Ultrastruct Pathol; 2011 Dec; 35(6):245-50. PubMed ID: 21932989
[TBL] [Abstract][Full Text] [Related]
3. A descriptive investigation of the ultrastructure of fibrin networks in thrombo-embolic ischemic stroke.
Pretorius E; Swanepoel AC; Oberholzer HM; van der Spuy WJ; Duim W; Wessels PF
J Thromb Thrombolysis; 2011 May; 31(4):507-13. PubMed ID: 21221717
[TBL] [Abstract][Full Text] [Related]
4. Macrothrombocytopenia: investigating the ultrastructure of platelets and fibrin networks using scanning and transmission electron microscopy.
Pretorius E; Oberholzer HM; van der Spuy WJ; Meiring JH
Ultrastruct Pathol; 2009 Oct; 33(5):216-21. PubMed ID: 19895294
[TBL] [Abstract][Full Text] [Related]
5. Investigating the effect of a platelet additive solution on apheresis platelet and fibrin network ultrastructure.
Pretorius E; Crookes R; Oberholzer HM; van der Spuy WJ
Transfus Apher Sci; 2010 Dec; 43(3):347-351. PubMed ID: 21036668
[TBL] [Abstract][Full Text] [Related]
6. Scanning electron microscopy investigation of fibrin networks after thermal injury.
Pretorius E; Olivier J; Oberholzer HM; Van der Spuy WJ
Onderstepoort J Vet Res; 2011 Jul; 78(1):244. PubMed ID: 23327209
[TBL] [Abstract][Full Text] [Related]
7. Plasma leptin and adiponectin levels in hormone replacement therapy and contraception: effects of different progestogens.
Di Carlo C; Tommaselli GA; De Rosa N; Fabozzi A; Santoro R; Bifulco G; Sparice S; Nappi C
Fertil Steril; 2011 Jul; 96(1):214-9. PubMed ID: 21645895
[TBL] [Abstract][Full Text] [Related]
8. Comparing techniques: the use of recalcified plasma in comparison with citrated plasma alone and in combination with thrombin in ultrastructural studies.
Pretorius E; Oberholzer HM; van der Spuy WJ; Franz RC
Hematology; 2011 Nov; 16(6):337-40. PubMed ID: 22183067
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
10. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
Br J Haematol; 1993 Apr; 83(4):616-21. PubMed ID: 8518178
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
[TBL] [Abstract][Full Text] [Related]
12. Age-related changes in fibrin networks and platelets of individuals over 75: a scanning electron microscopy study showing "thrombotic preparedness".
Pretorius E; Oberholzer HM; van der Spuy WJ; Meiring JH
J Thromb Thrombolysis; 2010 Apr; 29(3):271-5. PubMed ID: 20063043
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives, hormone replacement therapy and thrombosis.
Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
Thromb Haemost; 2001 Jul; 86(1):112-23. PubMed ID: 11486996
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural comparison of the morphology of three different platelet and fibrin fiber preparations.
Pretorius E; Briedenhann S; Marx J; Smit E; Van Der Merwe C; Pieters M; Franz C
Anat Rec (Hoboken); 2007 Feb; 290(2):188-98. PubMed ID: 17441211
[TBL] [Abstract][Full Text] [Related]
15. Comparative ultrastructure of fibrin networks of a dog after thrombotic ischaemic stroke.
Pretorius E; Windberger UB; Oberholzer HM; Auer RE
Onderstepoort J Vet Res; 2010 Nov; 77(1):E1-4. PubMed ID: 23327160
[TBL] [Abstract][Full Text] [Related]
16. Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes.
Pretorius E; Oberholzer HM; van der Spuy WJ; Swanepoel AC; Soma P
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):463-7. PubMed ID: 21467917
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment.
Kluft C; Leuven JA; Helmerhorst FM; Krans HM
Vascul Pharmacol; 2002 Aug; 39(3):149-54. PubMed ID: 12616983
[TBL] [Abstract][Full Text] [Related]
18. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
[TBL] [Abstract][Full Text] [Related]
19. Contraception for women with diabetes: an update.
Skouby SO; Mølsted-Pedersen L; Petersen KR
Baillieres Clin Obstet Gynaecol; 1991 Jun; 5(2):493-503. PubMed ID: 1954724
[TBL] [Abstract][Full Text] [Related]
20. Effects of low and high dose oral contraceptives on blood coagulation and thrombogenesis induced by vascular subendothelium exposed to flowing human blood.
Inauen W; Stocker G; Haeberli A; Straub PW
Contraception; 1991 May; 43(5):435-46. PubMed ID: 1833126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
